Breast cancer treatment: Drug pertuzumab licensed

Thousands of women with early but aggressive breast cancer could benefit from a drug that has been approved by UK regulators, say experts.

Pertuzumab (Perjeta) fights HER2-positive breast cancer and its new licence means it can be used before surgery to shrink and control tumours.

Click to read more.

Leave a Reply

© 2021 Copyright 2021 Katie Estruch Biology Terms & Conditions | Privacy Policy